In this review:
The EBCTCG Oxford overview 1984–2012
Triple negative breast cancer
The biology of metastasis in breast cancer
Routine adjuvant bisphosphonates not advised
Risk factors for breast cancer
SC vs IV trastuzumab in HER2+ disease
Everolimus + exemestane: bone h
Please login below to download this issue (PDF)